ストックスクリーナーアプリを入手
5.54
1.60%
-0.09
Fennec Pharmaceuticals Inc (FENC) 最新ニュース
Fennec Pharmaceuticals Inc (NASDAQ:FENC) Sees Large Decrease in Short Interest - MarketBeat
Learn to Evaluate (FENC) using the Charts - Stock Traders Daily
Fennec Pharmaceuticals Inc. (TSE:FRX) Director Sells C$87,552.00 in Stock - MarketBeat
Barclays PLC Grows Position in Fennec Pharmaceuticals Inc (NASDAQ:FENC) - Defense World
Rosty Raykov Sells 10,000 Shares of Fennec Pharmaceuticals Inc (NASDAQ:FENC) Stock - MarketBeat
Fennec Pharmaceuticals director Raykov Rosty sells $60,800 in shares By Investing.com - Investing.com Australia
Fennec Pharmaceuticals director Raykov Rosty sells $60,800 in shares - Investing.com
Franklin Resources Inc. Has $74,000 Holdings in Fennec Pharmaceuticals Inc (NASDAQ:FENC) - Defense World
State Street Corp Has $1.64 Million Stake in Fennec Pharmaceuticals Inc (NASDAQ:FENC) - Defense World
Fennec Pharmaceuticals (TSE:FRX) Shares Pass Above 50 Day Moving AverageShould You Sell? - MarketBeat
Stocks In Play: Fennec Pharmaceuticals Inc. - Barchart
(FENC) Trading Advice - Stock Traders Daily
Wedbush Raises Earnings Estimates for Fennec Pharmaceuticals - Defense World
Q4 EPS Estimate for Fennec Pharmaceuticals Raised by Analyst - MarketBeat
Wedbush Issues Optimistic Outlook for TSE:FRX Earnings - Defense World
Equities Analysts Issue Forecasts for TSE:FRX Q3 Earnings - MarketBeat
Fennec Pharmaceuticals Announces Pedmarqsi Positive Recommendation by NICE for the Prevention of Cisplatin-Induced Hearing Loss in England and Wales - Marketscreener.com
Fennec Pharmaceuticals Inc. (TSE:FRX) Director Acquires C$96,840.00 in Stock - MarketBeat
Fennec Pharmaceuticals’ (FENC) Outperform Rating Reiterated at Wedbush - Defense World
Fennec's Pedmarqsi gets nod from U.K. regulators - MSN
Long Term Trading Analysis for (FENC) - Stock Traders Daily
Fennec Pharmaceuticals (NASDAQ:FENC) Receives Outperform Rating from Wedbush - MarketBeat
Fennec Pharmaceuticals Inc. - Baystreet.ca
Fennec Pharmaceuticals Announces Pedmarqsi® Positive Recommendation by NICE for the Prevention of Cisplatin-Induced Hearing Loss in England and Wales - The Manila Times
Fennec's PEDMARQSI® Breakthrough: First NHS Treatment for Child Cancer-Related Hearing Loss - StockTitan
HC Wainwright Issues Negative Forecast for TSE:FRX Earnings - Defense World
What is HC Wainwright’s Forecast for FENC FY2024 Earnings? - Defense World
FY2024 Earnings Estimate for TSE:FRX Issued By HC Wainwright - MarketBeat
What is HC Wainwright's Estimate for FENC FY2024 Earnings? - MarketBeat
Fennec Pharmaceuticals partially repays its outstanding convertible debt facility - MSN
Fennec Pharmaceuticals Announces Early Partial Repayment of Its Outstanding Convertible Debt Facility with Petrichor Healthcare Capital Management - The Manila Times
Verition Fund Management LLC Sells 23,113 Shares of Fennec Pharmaceuticals Inc (NASDAQ:FENC) - Defense World
Fennec Pharmaceuticals' (FENC) Buy Rating Reaffirmed at HC Wainwright - MarketBeat
Fennec Pharmaceuticals Inc (NASDAQ:FENC) Shares Sold by BNP Paribas Financial Markets - Defense World
Stocks In Play: Fennec Pharmaceuticals Inc. By Baystreet.ca - Investing.com Canada
Fennec Pharmaceuticals (TSE:FRX) Trading Down 0.3% – Time to Sell? - Defense World
Fennec Pharmaceuticals (TSE:FRX) Stock Price Down 0.3%Time to Sell? - MarketBeat
Fennec Pharmaceuticals Inc (FRX-T) QuotePress Release - The Globe and Mail
Fennec Pharmaceuticals to Participate in Upcoming Investor Conference - The Manila Times
Fennec Pharmaceuticals to Present at H.C. Wainwright Fireside Chat Series - StockTitan
Where are the Opportunities in (FENC) - Stock Traders Daily
Fennec Pharmaceuticals director Raykov Rosty sells shares worth $4,807 - Investing.com
Fennec Pharmaceuticals director Raykov Rosty sells shares worth $4,807 By Investing.com - Investing.com Nigeria
Insider Sell: Rosty Raykov Sells Shares of Fennec Pharmaceuticals Inc (FENC) - GuruFocus.com
Fennec Pharmaceuticals director sells $10,022 in stock By Investing.com - Investing.com UK
Fennec Pharmaceuticals director sells $39,351 in shares By Investing.com - Investing.com Canada
Fennec Pharmaceuticals director sells $39,351 in shares - Investing.com India
A Data-Based Look At Fennec Pharmaceuticals Inc (FENC) - Stocks Register
0.65%
4.62%
大文字化:
|
ボリューム (24 時間):